Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Trubion Pharmaceuticals, Inc | v54725e10vk.htm |
| EX-32 - EX-32 - Trubion Pharmaceuticals, Inc | v54725exv32.htm |
| EX-31.2 - EX-31.2 - Trubion Pharmaceuticals, Inc | v54725exv31w2.htm |
| EX-31.1 - EX-31.1 - Trubion Pharmaceuticals, Inc | v54725exv31w1.htm |
| EX-10.30 - EX-10.30 - Trubion Pharmaceuticals, Inc | v54725exv10w30.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| (1) | Registration Statement (Form S-8 No. 333-139381) pertaining to the Trubion Pharmaceuticals, Inc. 2002 Stock Plan, the Trubion Pharmaceuticals, Inc. 2002 Equity Incentive Plan and the Trubion Pharmaceuticals, Inc. 2006 Equity Incentive Plan; and, |
| (2) | Registration Statement (Form S-8 Nos. 333-143056, 333-151439, and 333-158134) pertaining to the Trubion Pharmaceuticals, Inc. 2006 Equity Incentive Plan; |
of our reports dated March 15, 2010, with respect to the financial statements of Trubion
Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Trubion
Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) of Trubion Pharmaceuticals, Inc.
for the year ended December 31, 2009.
/s/ Ernst & Young LLP
Seattle, Washington
March 15, 2010
March 15, 2010